Fifth Third Bancorp
NUVB icon

Fifth Third Bancorp’s Nuvation Bio NUVB Stock Holding History

Fifth Third Bancorp’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$422 Hold
74
– – ﹤0.01% 4246
2026
Q1 		$319 Buy
+74
New +$412 ﹤0.01% 4221

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fifth Third Bancorp's NUVB Position: Q2 2026 in Review

Fifth Third Bancorp held its Nuvation Bio (NUVB) position steady in Q2 2026 at 74 shares worth $422. The position accounts for ﹤0.01% of the portfolio, ranked #4246.

Fifth Third Bancorp first reported a position in NUVB in Q1 2026 and has held it in 2 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Fifth Third Bancorp held 74 shares of Nuvation Bio worth $422 as of Q2 2026.
  • Fifth Third Bancorp left its Nuvation Bio share count unchanged in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4246 holding.
  • Fifth Third Bancorp first reported a position in Nuvation Bio in Q1 2026 and has held it in 2 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.